|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.625 USD | -2.69% |
|
-8.19% | -13.56% |
| 06-15 | Waldencast plc Announces Fda Approval of Obagi Saypha Chiq Injectable Hyaluronic Acid Gel | CI |
| 06-15 | Waldencast Says US FDA Approves Obagi Saypha ChIQ Injectable Hyaluronic Acid Gel | MT |
| Market Cap | 197M 174M 162M 149M 278M 18.91B 285M 1.92B 751M 9.36B 741M 725M 32.35B | P/E 2026 * |
-2.33x | P/E 2027 * | -2.49x |
|---|---|---|---|---|---|
| Enterprise Value | 306M 269M 251M 230M 431M 29.3B 442M 2.97B 1.16B 14.5B 1.15B 1.12B 50.12B | EV / Sales 2026 * |
1.07x | EV / Sales 2027 * | 0.97x |
| Free-Float |
46.06% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.69% | ||
| 1 week | -8.19% | ||
| Current month | -7.67% | ||
| 1 month | +8.33% | ||
| 3 months | +112.98% | ||
| 6 months | +1.88% | ||
| Current year | -13.56% |
| 1 week | 1.61 |  | 1.74 |
| 1 month | 1.6 | | 1.86 |
| Current year | 0.72 | | 2.01 |
| 1 year | 0.72 | | 3.22 |
| 3 years | 0.72 | | 12 |
| 5 years | 0.72 | | 12.1 |
| 10 years | 0.72 | | 12.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hind Sebti
COO | Chief Operating Officer | 47 | 2020-12-07 |
Michel Brousset
CEO | Chief Executive Officer | 53 | 2020-12-07 |
Manual Manfredi
DFI | Director of Finance/CFO | 50 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michel Brousset
BRD | Director/Board Member | 53 | 2020-12-07 |
| Chairman | 60 | 2020-12-31 | |
Hind Sebti
BRD | Director/Board Member | 47 | 2024-09-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/18/26 | Zeno Equity Partners LLP
| Other | Company | 17,145,347 | 14.5273% | |
| 3/18/26 | Waldencast Management LLC
| Other | Company | 6,583,613 | 5.5783% | |
| 3/18/26 | Other | Director | 118,727 | 0.1006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.69% | -8.19% | -21.12% | -70.18% | 199M | |
| +0.21% | +1.68% | +36.89% | +49.74% | 35.36B | |
| +1.31% | +5.08% | -1.08% | +14.08% | 21.56B | |
| -0.73% | -2.79% | -0.06% | - | 10.58B | |
| -3.90% | -1.79% | -36.33% | -46.09% | 4.13B | |
| +6.04% | +13.74% | +48.30% | +41.52% | 2.23B | |
| -0.87% | -3.15% | -25.51% | - | 990M | |
| -1.39% | -1.67% | - | - | 507M | |
| -2.09% | -2.60% | -20.76% | +151.01% | 421M | |
| 0.00% | +4.49% | +50.00% | -34.04% | 368M | |
| Average | -0.41% | +1.68% | +3.37% | +15.15% | 7.64B | |
| Weighted average by Cap. | +0.29% | +2.64% | +16.07% | +31.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 286M 251M 234M 215M 403M 27.38B 413M 2.78B 1.09B 13.55B 1.07B 1.05B 46.84B | 315M 277M 258M 237M 444M 30.15B 454M 3.06B 1.2B 14.92B 1.18B 1.16B 51.58B |
| Net income | -81.16M -71.31M -66.57M -61.09M -114M -7.77B -117M -789M -309M -3.85B -305M -298M -13.3B | -76.15M -66.91M -62.45M -57.32M -107M -7.29B -110M -741M -290M -3.61B -286M -280M -12.48B |
| Net Debt | 108M 95.25M 88.91M 81.6M 153M 10.38B 157M 1.05B 412M 5.14B 407M 398M 17.76B | 107M 94.28M 88.01M 80.77M 151M 10.28B 155M 1.04B 408M 5.09B 403M 394M 17.58B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-29 | US$1.625 | -2.69% | 451,652 |
| 26-07-28 | US$1.670 | -2.91% | 248,224 |
| 26-07-27 | US$1.720 | +1.78% | 433,308 |
| 26-07-24 | US$1.690 | -2.87% | 339,371 |
| 26-07-23 | US$1.740 | -1.69% | 675,219 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WALD Stock
Select your edition
All financial news and data tailored to specific country editions
